Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| no clinical added value |
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients. |
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
UUw0HCQ26mvdmPaR
